Skip to content

Drug interactions

Entacapone + Pacritinib

Severity: Minor

Entacapone and Pacritinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib is metabolized by CYP3A4, and strong inhibitors raise its exposure and the risk of QT prolongation, bleeding and diarrhea. Entacapone is not an established CYP3A4 inhibitor, so the interaction is theoretical.

What this interaction means in plain words

Entacapone and Pacritinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Entacapone belongs to Central Nervous System; Pacritinib belongs to Oncology.

Evidence level: Low

Why it happens

Theoretical CYP3A4 inhibition by entacapone; not established clinically.

What to do

No empirical dose change is needed; monitor for pacritinib adverse effects including bleeding and QT changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Entacapone and Pacritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Entacapone with Pacritinib?

MediHelp rates the interaction as minor. Entacapone and Pacritinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pacritinib is metabolized by CYP3A4, and strong inhibitors raise its exposure and the risk of QT prolongation, bleeding and diarrhea. Entacapone is not an established CYP3A4 inhibitor, so the interaction is theoretical.

How serious is the interaction between Entacapone and Pacritinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed; monitor for pacritinib adverse effects including bleeding and QT changes.

What other medicines interact with Entacapone?

MediHelp also lists interactions of Entacapone with, for example, Isocarboxazid, Phenelzine, Tranylcypromine. The full list is on the Entacapone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in